Previous studies demonstrated that water film thickness (WFT) is a key factor that affects the fluidity of mortar. Changes in the sand-cement (S/C) ratio and polycarboxylate superplasticizer (PCE) dosage will affect the WFT. In this study, several mortar samples with different S/C ratios and different PCE dosages were prepared, and the basic properties of the mortar were measured. The results show that as the S/C ratio increases, the packing density of the mortar will decrease, the WFT will decrease, and the cohesiveness will increase, resulting in a decrease in the flow spread and strength of the mortar. When the PCE dosage is increased, the packing density of the mortar will increase, the WFT will increase, and the cohesiveness will decrease, which increases the flow spread of the mortar. When the water-cement (W/C) ratio is low, the S/C ratio has a significant effect on the strength, and the strength will increase with the increasing of the PCE dosage. When the W/C ratio is high, the strength of the mortar will be reduced once the PCE dosage exceeds the saturation value. In the case of different S/C ratios or different PCE dosages, the WFT can be used as a measure of mortar cohesiveness and flow spread.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432667PMC
http://dx.doi.org/10.3390/ma14174850DOI Listing

Publication Analysis

Top Keywords

pce dosage
16
will increase
16
s/c ratio
12
mortar will
12
will decrease
12
flow spread
12
mortar
10
will
9
ratio polycarboxylate
8
polycarboxylate superplasticizer
8

Similar Publications

Five phenolic Schiff bases (-) incorporating a fragment of methanesulfonamide were synthesized and evaluated for their efficacy as antitumor agents. Compounds and demonstrated the most potent antitumor action, with a positive cytotoxic effect (PCE) of 54/59 and 59/59 and a mean growth percentage (MG%) of 67.3% and 19.

View Article and Find Full Text PDF

The cement industry is of great importance in terms of raw materials consumed, energy consumed, and greenhouse gases emitted. Grinding aids (GA) are used to reduce energy consumption and costs, as well as to reduce the amount of CO released into the environment. In this study, the effect of GA-polycarboxylate ether-based water-reducing admixture (PCE) compatibility on some fresh, rheological and hardened state properties of cementitious systems was investigated.

View Article and Find Full Text PDF

A vaccine candidate based on baculovirus displaying chikungunya virus E1-E2 envelope confers protection against challenge in mice.

J Virol

November 2024

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín (UNSAM) - Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.

Article Synopsis
  • - Chikungunya fever, caused by the chikungunya virus (CHIKV), leads to acute arthritis that may develop into chronic pain, with a recently approved vaccine not widely accessible in endemic areas.
  • - A new vectored vaccine using baculovirus technology shows promise by presenting CHIKV proteins E1 and E2 on its surface, eliciting strong immune responses in tested mice, including the production of neutralizing antibodies.
  • - Mice receiving two doses of this baculovirus-based vaccine were fully protected from CHIKV infection, highlighting its potential as an effective vaccine platform against this re-emerging disease amidst its surge in cases, particularly in the Americas.
View Article and Find Full Text PDF
Article Synopsis
  • * A study showed that an extract from a functional edible fungus (PCE) reduced brain damage and hemorrhage in rat models treated with tPA, suggesting a protective effect of this extract after ischemic stroke.
  • * PCE appears to regulate the balance between pro-inflammatory (M1) and anti-inflammatory (M2) microglial responses, reducing harmful inflammation and promoting healing by affecting specific protein expressions related to microglial polarization.
View Article and Find Full Text PDF
Article Synopsis
  • * SAB-163 is a new therapeutic treatment developed from transchromosomic bovine plasma, showing strong effectiveness against multiple hantavirus strains and extended bioavailability in animal models.
  • * The treatment has demonstrated protective effects in hamsters when administered around the time of exposure and is now ready for phase 1 clinical trials after passing safety and efficacy tests.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!